This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations by Josè M Carballido Herrera
Introduction
Josè M Carballido Herrera is a notable inventor based in Perchtoldsdorf, Austria. He has made significant contributions to the field of therapeutic binding molecules, showcasing his expertise and innovative spirit. His work is particularly relevant in the pharmaceutical industry, where his inventions can lead to advancements in medical treatments.
Latest Patents
Josè M Carballido Herrera holds a patent for therapeutic binding molecules. This patent describes a molecule that comprises at least one antigen binding site, which includes specific amino acid sequences for hypervariable regions CDR1, CDR2, and CDR3. The sequences are as follows: CDR1 has the amino acid sequence Asn-Tyr-Ile-Ile-His (NYIIH), CDR2 has Tyr-Phe-Asn-Pro-Tyr-Asn-His-Gly-Thr-Lys-Tyr-Asn-Glu-Lys-Phe-Lys-Gly (YFNPYNHGTKYNEKFKG), and CDR3 has Ser-Gly-Pro-Tyr-Ala-Trp-Phe-Asp-Thr (SGPYAWFDT). This invention may also include additional hypervariable regions, making it useful as a chimeric or humanized antibody in pharmaceutical applications.
Career Highlights
Josè M Carballido Herrera is associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies. His patent reflects his commitment to advancing medical science and providing solutions for complex health issues.
Collaborations
Throughout his career, Josè has collaborated with esteemed colleagues such as Gregorio Aversa and Frank Kolbinger. These partnerships have likely contributed to the success of his projects and the development of impactful inventions in the pharmaceutical field.
Conclusion
Josè M Carballido Herrera is a distinguished inventor whose work in therapeutic binding molecules has the potential to revolutionize pharmaceutical treatments. His contributions, along with his collaborations, highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile